Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway

<div>Nomogram and calibration plot. (a) Nomogram used to predict the 1-, 3-, and 5-year OS rates of patients with RCC. (b) Calibration plot of the nomogram utilized in predicting OS probability. Correlation between S100A16 and immune cells in the TIMER database.</div>

Contrast Media & Molecular Imaging

fig4

Figure 4

Figure 4: Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway 